Clinical Trial Update: Effect of Palivizumab on Later Recurrent Wheezing in Preterm Infants

View source ↗

Summary

Completed trial evaluating whether palivizumab given to preterm infants influences the development of later recurrent wheezing or asthma-like symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Wheezing

Drugs mentioned

• Synagis (palivizumab)

Snippet

Sponsor: Satoshi Kusuda | Conditions: Recurrent Wheezing, Wheezing | Status: COMPLETED